Log in

7 Pharma Stocks to Avoid at All Costs in 2019 - 1 of 8

 
7 Pharma Stocks to Avoid at All CostsThe pharmaceutical sector has been on a roller coaster ride over the last several years. As recently as 2016, the industry was getting pinched by the double whammy of pressure to reduce drug costs and a corporate tax structure that was choking off topline growth. In the last year, many of the pharmaceutical companies have seen their stocks go through the roof as a result of the new tax policy. But not every pharmaceutical stock is showing strength.

Make no mistake, this is an industry that every investor – and every consumer – should want to see succeed. These companies are continuously introducing new drugs and treatments for cancer, Alzheimer’s, diabetes, and multiple sclerosis just to name a few. And that’s not to mention the drugs that help us manage our cholesterol, high blood pressure, and depression.

Not to mention, the baby boomer generation continues to reach retirement age. In 2018 alone, over three million people will be reaching retirement age and that pace isn’t expected to slow down significantly until 2029. As the number of retirees expands so too will their need for the products and services that come from this industry.

It’s expensive to develop these drugs, not to mention that it can take years for some of these products to reach the market. Our desire to want to believe in these treatments can allow investors to mistake an inflated valuation for a poor valuation.

But as an investor, we have to perform our due diligence, and there are some stocks that have qualitative or quantitative factors working against them. While the pharmaceutical is always changing, we’re providing a list of seven stocks that, for now, should stay out of your portfolio.

Click the "Continue to Slide #2" button view the first company.





More on MarketBeat
10 Rock-Solid Dividend Paying Stocks to Own10 Rock-Solid Dividend Paying Stocks to Own
20 Stocks Analysts Can20 Stocks Analysts Can't Stop Upgrading
10 Canadian Growth Stocks to Buy Now10 Canadian Growth Stocks to Buy Now
15 Healthcare Stocks that Analysts Love15 Healthcare Stocks that Analysts Love
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Portfolio20 High-Yield Dividend Stocks that Could Ruin Your Retirement Portfolio
7 Best Stocks to Own Right Now7 Best Stocks to Own Right Now
Top Fifteen Highest-Rated Dividend CompaniesTop Fifteen Highest-Rated Dividend Companies



Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel